The burgeoning landscape of therapy for obesity and type 2 diabetes is currently witnessing considerable attention surrounding both retatrutide and tirzepatide. While both represent novel dual GIP and GLP-1 receptor https://aishalssz283535.shoutmyblog.com/37764557/retatrutide-vs-tirzepatide-a-comparative-analysis